A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Relapsed or Refractory Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States

  • UCSF, San Francisco, California, United States

  • Emory University Hospital, Atlanta, Georgia, United States

  • Mass General Brigham, Boston, Massachusetts, United States

  • Tisch Cancer Institute at Mount Sinai, New York, New York, United States

  • Memorial Sloan-Kettering Cancer Center, New York, New York, United States

  • Atrium Health Levine Cancer Institute, Charlotte, North Carolina, United States

  • Penn Medicine, Philadelphia, Pennsylvania, United States

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

  • The Medical College of Wisconsin, Milwaukee, Wisconsin, United States